参考文献/References:
[1]李佃贵.消化性溃疡浊毒论/李佃贵浊毒理论临床经验实录丛书[M].北京:中国科学技术出版社,2016:1-5. [2]王宇阳,马放,占永立.基于“浊毒”理论论治慢性肾脏病[J].中医杂志,2019,60(16):1374-1377. [3]章天寿.张杰主任医师学术思想与临床经验总结及补肾降浊法治疗高脂血症的临床研究[D].南京中医药大学,2015. [4]白亚楠,谷诺诺,杨倩.从浊毒论治肠易激综合征[J].湖北中医杂志,2018,40(4):35-37. [5]何道同,王兵,陈珺明.疏肝健脾-脂肪肝中医治疗的基础[J].浙江中医药大学学报,2013(5):651-652.
相似文献/References:
[1]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,31(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Medical Information,2018,31(04):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[2]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Medical Information,2022,35(04):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
[3]冯贺强,张彩红.肠道菌群与非酒精性脂肪肝关系的研究进展[J].医学信息,2018,31(12):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
FENG He-qiang,ZHANG Cai-hong.Research Progress on the Relationship between Intestinal Flora and Nonalcoholic Fatty Liver[J].Medical Information,2018,31(04):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
[4]郑 颖,孙华胜,毛乾国.中医防治非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(15):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
ZHENG Ying,SUN Hua-sheng,MAO Qian-guo.Progress in Prevention and Treatment of Nonalcoholic Fatty Liver Disease by TCM[J].Medical Information,2018,31(04):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
[5]李珊珊,陈少彬,龚先琼.中药单体治疗非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(21):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
LI Shan-shan,CHEN Shao-bin,GONG Xian-qiong.Advances in Research of Traditional Chinese Medicine Monomer in the Treatment of
Non-alcoholic Fatty Liver Disease[J].Medical Information,2018,31(04):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
[6]黄玲玉,孙 东,蒋本君,等.天津市某区域体检人群非酒精性脂肪肝调查分析[J].医学信息,2019,32(04):99.[doi:10.3969/j.issn.1006-1959.2019.04.032]
HUANG Ling-yu,SUN Dong,JIANG Ben-jun,et al.Investigation and Analysis of Non-alcoholic Fatty Liver Disease in Medical Examination Population in
A Certain Area of Tianjin[J].Medical Information,2019,32(04):99.[doi:10.3969/j.issn.1006-1959.2019.04.032]
[7]余 辉,李 岳,郭宝娜.非酒精性脂肪性肝病的治疗研究[J].医学信息,2019,32(14):38.[doi:10.3969/j.issn.1006-1959.2019.14.014]
YU Hui,LI Yue,GUO Bao-na.Treatment of Non-alcoholic Fatty Liver Disease[J].Medical Information,2019,32(04):38.[doi:10.3969/j.issn.1006-1959.2019.14.014]
[8]王佳欣,毛乾国.慢性乙型肝炎合并非酒精性脂肪性肝病
中医辨治的研究进展[J].医学信息,2019,32(16):38.[doi:10.3969/j.issn.1006-1959.2019.16.012]
WANG Jia-xin,MAO Qian-guo.Advances in Research on TCM Syndrome Differentiation of Chronic Hepatitis B with
Nonalcoholic Fatty Liver Disease[J].Medical Information,2019,32(04):38.[doi:10.3969/j.issn.1006-1959.2019.16.012]
[9]蔡秀媛,吴春城,梁惠卿,等.非酒精性脂肪性肝病中医证型与客观指标的相关性[J].医学信息,2020,33(09):21.[doi:10.3969/j.issn.1006-1959.2020.09.008]
CAI Xiu-yuan,WU Chun-cheng,LIANG Hui-qing,et al.Correlation Between TCM Syndromes of Nonalcoholic Fatty Liver Disease and Objective Indexes[J].Medical Information,2020,33(04):21.[doi:10.3969/j.issn.1006-1959.2020.09.008]
[10]徐云云,刘尚全.钠-葡萄糖协同转运蛋白2抑制剂治疗2型糖尿病合并非酒精性脂肪肝病的研究[J].医学信息,2021,34(01):33.[doi:10.3969/j.issn.1006-1959.2021.01.010]
XU Yun-yun,LIU Shang-quan.Study of Sodium-glucose Cotransporter 2 Inhibitor in the Treatment of Type 2 Diabetes with Non-alcoholic Fatty Liver Disease[J].Medical Information,2021,34(04):33.[doi:10.3969/j.issn.1006-1959.2021.01.010]